Nabel said no vaccine being tested today "is likely to hit it out of the park," but many researchers do feel advances in broadly neutralizing antibodies are key to developing a highly successful HIV vaccine. "It's really a new day when we start to think about where we are with AIDS vaccines," Nabel said.